{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:51:59Z","timestamp":1788547919044,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03961-7","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:05:14Z","timestamp":1763129114000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["LINC01063 promotes colon cancer progression via the miR-134-5p\/KRAS axis and serves as a prognostic biomarker"],"prefix":"10.1007","volume":"16","author":[{"given":"Qianli","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"3961_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global Cancer Statistics. 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians. 2021;71(3):209\u2009\u2013\u200949. https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"issue":"12","key":"3961_CR2","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Reviews Gastroenterol Hepatol. 2019;16(12):713\u201332. https:\/\/doi.org\/10.1038\/s41575-019-0189-8.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"7","key":"3961_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: A review. JAMA. 2021;325(7):669\u201385. https:\/\/doi.org\/10.1001\/jama.2021.0106.","journal-title":"JAMA"},{"key":"3961_CR4","doi-asserted-by":"publisher","unstructured":"Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, et al. Colorectal cancer incidence patterns in the united States, 1974\u20132013. JNCI J Natl Cancer Inst. 2017;109(8). https:\/\/doi.org\/10.1093\/jnci\/djw322.","DOI":"10.1093\/jnci\/djw322"},{"issue":"9927","key":"3961_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/s0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490\u2013502. https:\/\/doi.org\/10.1016\/s0140-6736(13)61649-9.","journal-title":"Lancet"},{"issue":"8","key":"3961_CR6","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","volume":"27","author":"E Van Cutsem","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, Sobrero A, Van Krieken JH, Aderka D, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386\u2013422. https:\/\/doi.org\/10.1093\/annonc\/mdw235.","journal-title":"Ann Oncol"},{"issue":"7483","key":"3961_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature12986","volume":"505","author":"Y Tay","year":"2014","unstructured":"Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of CeRNA crosstalk and competition. Nature. 2014;505(7483):344\u201352. https:\/\/doi.org\/10.1038\/nature12986.","journal-title":"Nature"},{"issue":"2","key":"3961_CR8","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.cell.2011.09.032","volume":"147","author":"A Karreth Florian","year":"2011","unstructured":"Karreth Florian A, Tay Y, Perna D, Ala U, Tan Shen M, Rust Alistair G, et al. In vivo identification of Tumor- suppressive PTEN CeRNAs in an oncogenic BRAF-Induced mouse model of melanoma. Cell. 2011;147(2):382\u201395. https:\/\/doi.org\/10.1016\/j.cell.2011.09.032.","journal-title":"Cell"},{"key":"3961_CR9","doi-asserted-by":"publisher","first-page":"111389","DOI":"10.1016\/j.biopha.2021.111389","volume":"137","author":"K Su","year":"2021","unstructured":"Su K, Wang N, Shao Q, Liu H, Zhao B, Ma S. The role of a CeRNA regulatory network based on LncRNA MALAT1 site in cancer progression. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2021;137:111389. https:\/\/doi.org\/10.1016\/j.biopha.2021.111389.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"3961_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fgene.2020.00318","volume":"11","author":"Y Lin","year":"2020","unstructured":"Lin Y, Pan X, Chen Z, Lin S, Chen S. Identification of an Immune-Related Nine-lncRNA signature predictive of overall survival in colon cancer. Front Genet. 2020;11:318. https:\/\/doi.org\/10.3389\/fgene.2020.00318.","journal-title":"Front Genet"},{"issue":"4","key":"3961_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/cmr.0000000000000803","volume":"32","author":"J Xu","year":"2022","unstructured":"Xu J, Ou R, Nie G, Wen J, Ling L, Mo L, et al. LINC01063 functions as an oncogene in melanoma through regulation of miR-5194-mediated SOX12 expression. Melanoma Res. 2022;32(4):218\u201330. https:\/\/doi.org\/10.1097\/cmr.0000000000000803.","journal-title":"Melanoma Res"},{"key":"3961_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/2767484","volume":"2017","author":"W Yang","year":"2017","unstructured":"Yang W, Ning N, Jin X. The LncRNA H19 promotes cell proliferation by competitively binding to miR-200a and derepressing \u03b2-Catenin expression in colorectal cancer. Biomed Res Int. 2017;2017:1\u20138. https:\/\/doi.org\/10.1155\/2017\/2767484.","journal-title":"Biomed Res Int"},{"issue":"7","key":"3961_CR13","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522\u201331. https:\/\/doi.org\/10.1038\/nrg1379.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"3961_CR14","doi-asserted-by":"publisher","first-page":"114385","DOI":"10.1016\/j.yexcr.2024.114385","volume":"444","author":"G Jothimani","year":"2025","unstructured":"Jothimani G, Das D, Pathak S, Malayaperumal S, Zhang H, Sun XF, et al. Unraveling the mechanism of microRNA-134 in colon cancer progression: targeting KRAS and PIK3CA for cell cycle control and histone deacetylase regulation. Exp Cell Res. 2025;444(2):114385. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114385.","journal-title":"Exp Cell Res"},{"issue":"1","key":"3961_CR15","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/s41598-017-01459-z","volume":"7","author":"K Agarwal","year":"2017","unstructured":"Agarwal K, Hariprasad G, Rani K, Sharma U, Mathur SR, Seenu V, et al. Is there an association between enhanced choline and \u03b2-catenin pathway in breast cancer? A pilot study by MR spectroscopy and ELISA. Sci Rep. 2017;7(1):2221. https:\/\/doi.org\/10.1038\/s41598-017-01459-z.","journal-title":"Sci Rep"},{"key":"3961_CR16","doi-asserted-by":"publisher","unstructured":"Pan JY, Zhang F, Sun CC, Li SJ, Li G, Gong FY et al. miR-134: A human cancer suppressor? Molecular therapy nucleic acids. 2017;6:140\u20139. https:\/\/doi.org\/10.1016\/j.omtn.2016.11.003","DOI":"10.1016\/j.omtn.2016.11.003"},{"issue":"24","key":"3961_CR17","doi-asserted-by":"publisher","first-page":"35960","DOI":"10.18632\/oncotarget.8482","volume":"7","author":"CC Sun","year":"2016","unstructured":"Sun CC, Li SJ, Li DJ. Hsa-miR-134 suppresses non-small cell lung cancer (NSCLC) development through down-regulation of CCND1. Oncotarget. 2016;7(24):35960\u201378. https:\/\/doi.org\/10.18632\/oncotarget.8482.","journal-title":"Oncotarget"},{"issue":"10","key":"3961_CR18","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/modpathol.2014.33","volume":"27","author":"M-d Xu","year":"2014","unstructured":"Xu M-d, Qi P, Du X. Long non-coding RNAs in colorectal cancer: implications for pathogenesis and clinical application. Mod Pathol. 2014;27(10):1310\u201320. https:\/\/doi.org\/10.1038\/modpathol.2014.33.","journal-title":"Mod Pathol"},{"key":"3961_CR19","doi-asserted-by":"publisher","unstructured":"Lin Y, Zhao W, Pu R, Lv Z, Xie H, Li Y, et al. Long non\u2013coding RNAs as diagnostic and prognostic biomarkers for colorectal cancer (Review). Oncol Lett. 2024;28(4). https:\/\/doi.org\/10.3892\/ol.2024.14619.","DOI":"10.3892\/ol.2024.14619"},{"issue":"8","key":"3961_CR20","doi-asserted-by":"publisher","first-page":"e18493","DOI":"10.1016\/j.heliyon.2023.e18493","volume":"9","author":"J Qu","year":"2023","unstructured":"Qu J, Tao D, Huang W, Lu L, Fan J, Zhang S, et al. Assessment of prognostic role of a novel 7-lncRNA signature in HCC patients. Heliyon. 2023;9(8):e18493. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18493.","journal-title":"Heliyon"},{"key":"3961_CR21","doi-asserted-by":"publisher","first-page":"153534","DOI":"10.1016\/j.prp.2021.153534","volume":"224","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S, Asadi M, Sohrabi B, Arsang-Jang S, Mehravaran E, Taheri M, et al. Down-regulation of a panel of immune-related LncRNAs in breast cancer. Pathol Res Pract. 2021;224:153534. https:\/\/doi.org\/10.1016\/j.prp.2021.153534.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"3961_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7\u201330. https:\/\/doi.org\/10.3322\/caac.21590.","journal-title":"CA Cancer J Clin"},{"issue":"9927","key":"3961_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/s0140-6736(13)61649-9","volume":"383","author":"H Brenner","year":"2014","unstructured":"Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet (London England). 2014;383(9927):1490\u2013502. https:\/\/doi.org\/10.1016\/s0140-6736(13)61649-9.","journal-title":"Lancet (London England)"},{"issue":"5","key":"3961_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"2","key":"3961_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00428-016-1956-3","volume":"469","author":"MF M\u00fcller","year":"2016","unstructured":"M\u00fcller MF, Ibrahim AE, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Archiv: Int J Pathol. 2016;469(2):125\u201334. https:\/\/doi.org\/10.1007\/s00428-016-1956-3.","journal-title":"Virchows Archiv: Int J Pathol"},{"issue":"1","key":"3961_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.Cd-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1059.","journal-title":"Cancer Discov"},{"issue":"1 Suppl 1","key":"3961_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/sonc.2003.50027","volume":"30","author":"CA Ritter","year":"2003","unstructured":"Ritter CA, Arteaga CL. The epidermal growth factor receptor-tyrosine kinase: a promising therapeutic target in solid tumors. Semin Oncol. 2003;30(1 Suppl 1):3\u201311. https:\/\/doi.org\/10.1053\/sonc.2003.50027.","journal-title":"Semin Oncol"},{"key":"3961_CR28","doi-asserted-by":"publisher","unstructured":"Shi L, Middleton J, Jeon Y-J, Magee P, Veneziano D, Lagan\u00e0 A, et al. KRAS induces lung tumorigenesis through MicroRNAs modulation. Cell Death Dis. 2018;9(2). https:\/\/doi.org\/10.1038\/s41419-017-0243-9.","DOI":"10.1038\/s41419-017-0243-9"},{"issue":"9","key":"3961_CR29","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.annonc.2021.06.001","volume":"32","author":"M Reck","year":"2021","unstructured":"Reck M, Carbone DP, Garassino M, Barlesi F. Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches. Annals Oncology: Official J Eur Soc Med Oncol. 2021;32(9):1101\u201310. https:\/\/doi.org\/10.1016\/j.annonc.2021.06.001.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"issue":"9","key":"3961_CR30","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/1541-7786.Mcr-15-0203","volume":"13","author":"JC Hunter","year":"2015","unstructured":"Hunter JC, Manandhar A, Carrasco MA, Gurbani D, Gondi S, Westover KD. Biochemical and structural analysis of common Cancer-Associated KRAS mutations. Mol Cancer Research: MCR. 2015;13(9):1325\u201335. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-15-0203.","journal-title":"Mol Cancer Research: MCR"},{"issue":"12","key":"3961_CR31","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1158\/2159-8290.Cd-22-1467","volume":"13","author":"WH Hsu","year":"2023","unstructured":"Hsu WH, LaBella KA, Lin Y, Xu P, Lee R, Hsieh CE, et al. Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression. Cancer Discov. 2023;13(12):2652\u201373. https:\/\/doi.org\/10.1158\/2159-8290.Cd-22-1467.","journal-title":"Cancer Discov"},{"key":"3961_CR32","doi-asserted-by":"publisher","unstructured":"Saad MI, Alhayyani S, McLeod L, Yu L, Alanazi M, Deswaerte V, et al. ADAM17 selectively activates the IL-6 trans-signaling\/ERK MAPK axis in KRAS-addicted lung cancer. EMBO Mol Med. 2019;11(4). https:\/\/doi.org\/10.15252\/emmm.201809976.","DOI":"10.15252\/emmm.201809976"},{"issue":"1","key":"3961_CR33","doi-asserted-by":"publisher","first-page":"e3658","DOI":"10.1002\/jgm.3658","volume":"26","author":"L Xu","year":"2024","unstructured":"Xu L, Ding R, Song S, Liu J, Li J, Ju X, et al. Single-cell RNA sequencing reveals the mechanism of PI3K\/AKT\/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation. J Gene Med. 2024;26(1):e3658. https:\/\/doi.org\/10.1002\/jgm.3658.","journal-title":"J Gene Med"},{"issue":"1","key":"3961_CR34","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1186\/s12943-024-02157-x","volume":"23","author":"WJ McDaid","year":"2024","unstructured":"McDaid WJ, Wilson L, Adderley H, Martinez-Lopez A, Baker MJ, Searle J, et al. The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRAS(G12D)-driven non-small cell lung cancer. Mol Cancer. 2024;23(1):253. https:\/\/doi.org\/10.1186\/s12943-024-02157-x.","journal-title":"Mol Cancer"},{"key":"3961_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jep.2016.11.036","volume":"195","author":"TW Chung","year":"2017","unstructured":"Chung TW, Choi H, Lee JM, Ha SH, Kwak CH, Abekura F, et al. Oldenlandia diffusa suppresses metastatic potential through inhibiting matrix metalloproteinase-9 and intercellular adhesion molecule-1 expression via p38 and ERK1\/2 MAPK pathways and induces apoptosis in human breast cancer MCF-7 cells. J Ethnopharmacol. 2017;195:309\u201317. https:\/\/doi.org\/10.1016\/j.jep.2016.11.036.","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"3961_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.4111\/icu.20240250","volume":"65","author":"JN Ho","year":"2024","unstructured":"Ho JN, Byun SS, Kim D, Ryu H, Lee S. Dasatinib induces apoptosis and autophagy by suppressing the PI3K\/Akt\/mTOR pathway in bladder cancer cells. Invest Clin Urol. 2024;65(6):593\u2013602. https:\/\/doi.org\/10.4111\/icu.20240250.","journal-title":"Invest Clin Urol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03961-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03961-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03961-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T11:50:12Z","timestamp":1765972212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03961-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3961"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03961-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study received endorsement from the Ethics Committee of Harbin Traditional Chinese Medicine Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients provided their informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2206"}}